KEGG   DRUG: Emtricitabine and tenofovir disoproxil
Entry
D02297            Mixture   Drug                                   
Name
Emtricitabine and tenofovir disoproxil;
Truvada (TN)
Product
  Generic
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (A-S Medication Solutions), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (American Health Packaging), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Amneal Pharmaceuticals NY LLC), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Amneal Pharmaceuticals NY LLC), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Aurobindo Pharma Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Aurobindo Pharma Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (AvKARE), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Camber Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Cipla USA), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Cipla USA), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (DIRECT RX), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Direct Rx), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (DirectRx), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Exelan Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Golden State Medical Supply), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Laurus Labs Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Lupin Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Macleods Pharmaceuticals Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Major Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Mylan Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (NorthStar RxLLC), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Pharmasource Meds), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Pharmasource Meds), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Proficient Rx LP), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (QUALLENT PHARMACEUTICALS HEALTH LLC), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (RPK Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Redpharm Drug), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Redpharm Drug), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Redpharm Drug), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Redpharm Drug), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Strides Pharma Science Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Strides Pharma), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Teva Pharmaceuticals USA), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Zydus Lifesciences Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Zydus Pharmaceuticals USA), EMTRICITABINE/TDF (Direct_Rx)
Component
Emtricitabine [DR:D01199], (Tenofovir disoproxil fumarate [DR:D01982] | Tenofovir disoproxil phosphate [DR:D10834])
Class
Antiviral
 DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
 DG03107  Anti-HIV agent
Remark
Therapeutic category: 6250
ATC code: J05AR03
Product: D02297<JP/US>
Efficacy
Antiviral
  Disease
HIV-1 infection [DS:H01563]
Target
HIV-1 reverse transcriptase [KO:K24802]
  Pathway
ko03230  Viral genome structure
ko03240  Viral replication
ko03250  Viral life cycle - HIV-1
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR03 Tenofovir disoproxil and emtricitabine
      D02297  Emtricitabine and tenofovir disoproxil <JP/US>
USP drug classification [BR:br08302]
 Antivirals
  Anti-HIV Combinations
   Emtricitabine/ Tenofovir Disoproxil Fumarate
    D02297  Emtricitabine and tenofovir disoproxil
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D02297  Emtricitabine and tenofovir disoproxil
Drug groups [BR:br08330]
 Antiviral
  DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
   D02297  Emtricitabine and tenofovir disoproxil
  DG03107  Anti-HIV agent
   D02297  Emtricitabine and tenofovir disoproxil
Drug classes [BR:br08332]
 Antiviral
  DG03107  Anti-HIV agent
   D02297  Emtricitabine and tenofovir disoproxil
Antimicrobials [BR:br08307]
 Antivirals
  Genome replication inhibitor
   HIV reverse transcriptase inhibitor
    D02297  Emtricitabine and tenofovir disoproxil <JP/US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D02297
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D02297
Other DBs
PubChem: 7849356
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system